
Bloom, LANACOME, Origin Technologies Collaborate on Pharma Traceability in Cameroon
January 31, 2025
IVI and Bloom Public Health Group partner to advance vaccine equity and strengthen health security in Africa
December 10, 2025Bloom Public Health Cameroon is supporting national efforts to curb measles outbreaks through advocacy, public awareness, and continued investment in vaccine systems strengthening across Africa.
The Ministry of Public Health of Cameroon will conduct a targeted measles outbreak response vaccination campaign from 13–17 August 2025 across nine health districts in the Littoral, Centre, East, North, and South West regions.
The campaign aims to vaccinate all eligible children aged 9 months to 9 years, irrespective of their previous vaccination status, as part of an emergency response to confirmed measles outbreaks. The intervention is designed to interrupt disease transmission, prevent severe complications, and protect vulnerable children from one of the world’s most contagious vaccine-preventable diseases.
Measles remains a significant public health concern, particularly in communities with low immunization coverage. Beyond causing fever and rash, the disease can lead to life-threatening complications including pneumonia, encephalitis, blindness, and death. Vaccination continues to be the safest, most effective, and most cost-efficient intervention for preventing outbreaks and protecting population health.
Bloom Public Health Cameroon joins national health authorities, development partners, and healthcare professionals in encouraging parents and caregivers to ensure that every eligible child receives this life-saving vaccine. Community participation remains essential to achieving high vaccination coverage and preventing further transmission.
As part of its broader commitment to strengthening immunization systems across Africa, Bloom Public Health Group continues to invest in sustainable vaccine ecosystem development through the African Vaccine Academy (AVA). By building local expertise in vaccine science, manufacturing, quality systems, and regulatory capacity, AVA contributes to Africa’s long-term preparedness for infectious disease outbreaks while supporting the continent’s ambition to expand local vaccine production.
Protecting children from vaccine-preventable diseases requires coordinated action, strong health systems, and sustained investment in immunization. Bloom Public Health Cameroon remains committed to supporting initiatives that improve vaccine access, strengthen public health capacity, and contribute to healthier, more resilient communities across Africa.



